전신 PET/CT 영상 획득 시 투과 스캔에서의 방사선 선량

손혜경,이상훈,남소라,김희중,Son Hye-Kyung,Lee Sang-Hoon,Nam So-Ra,Kim Hee-Joung 한국의학물리학회 2006 의학물리 Vol.17 No.2

본 연구의 목적은 다양한 전압 값과 전류 값에 따른 CT 투과 스캔 동안의 방사선 선량을 측정하고, 우리 기관에서 사용하는 임상 전신 PET/CT 환자 영상 획득 방식 중 감쇠 보정을 위해 사용하는 $^{137}Cs$ 투과 스캔과 환자의 진단용 고화질 CT 투과 스캔에 대한 방사선 선량을 평가하는 것이다. 방사선 선량 측정을 위해 Philips GEMINI 16 슬라이스 PET/CT시스템을 이용하였다. 다양한 튜브 전압 값과 시간에 따른 전류 값에 대해 표준 CTDI 머리 팬텀과 몸 팬텀을 이용하여 선량을 측정하였다. 이때 100 mm의 유효 길이를 가지는 펜슬 이온 전리함과 전기계를 선량 측정에 이용하였다. 측정은 공기 중, 팬텀의 중심, 그리고 팬텀의 가장 자리에서 각각 이루어졌다. 평균 흡수선량인 가중 CTDI ($CTDI_w=1/3CTDI_{100,c}+2/3CTDI_{100,p}$) 값을 계산하고 이를 이용하여 등가 선량을 계산하였다. 본 연구자가 속한 기관에서의 전신 임상 PET/CT 영상 획득 방식을 이용한 투과 스캔에서의 방사선 선량 측정을 위해 Alderson 팬텀과 TLD를 이용하여 $^{137}Cs$ 투과 스캔과 고화질 CT투과 스캔을 각각 수행하여 각 인체 기관별 선량을 측정하였다. 측정에 사용한 TLD는 10 MeV X-선을 이용하여 교정한 후 ${\pm}5%$ 이내의 정확도를 가지는 것만 측정에 사용하였다. 장기 또는 조직은 ICRP 60을 참고로 선택하였다. 표준 CTDI 머리 팬텀과 몸 팬텀을 이용한 CT 투과 스캔에 대한 선량 측정 결과, 선량 값이 튜브 전압과 전류에 의존하는 것을 확인할 수 있었다. $^{137}Cs$ 투과 스캔과 고화질 CT 투과 스캔에 대한 유효 선량 측정 결과는 0.14 mSv와 29.49 mSv였다. PET/CT 시스템에서 표준 CTDI 팬텀과 이온 전리함, 그리고 Alderson 인체 팬텀과 TLD를 이용하여 투과 스캔에 대한 방사선 선량을 평가할 수 있었다. PET/CT 영상 획득 시, 우리가 원하는 영상의 화질을 유지하면서 환자에 대한 피폭을 최소화하기 위한 영상 획득 방식의 최적화가 추가적으로 이루어져야 할 것으로 생각한다. The purpose of this study was to evaluate the radiation doses during CT transmission scan by changing tube voltage and tube current, and to estimate the radiation dose during our clinical whole body $^{137}Cs$ transmission scan and high quality CT scan. Radiation doses were evaluated for Philips GEMINI 16 slices PET/CT system. Radiation dose was measured with standard CTDI head and body phantoms in a variety of CT tube voltage and tube current. A pencil ionization chamber with an active length of 100 mm and electrometer were used for radiation dose measurement. The measurement is carried out at the free-in-air, at the center, and at the periphery. The averaged absorbed dose was calculated by the weighted CTDI ($CTDI_w=1/3CTDI_{100,c}+2/3CTDI_{100,p}$) and then equivalent dose were calculated with $CTDI_w$. Specific organ dose was measured with our clinical whole body $^{137}Cs$ transmission scan and high quality CT scan using Alderson phantom and TLDs. The TLDs used for measurements were selected for an accuracy of ${\pm}5%$ and calibrated in 10 MeV X-ray radiation field. The organ or tissue was selected by the recommendations of ICRP 60. The radiation dose during CT scan is affected by the tube voltage and the tube current. The effective dose for $^{137}Cs$ transmission scan and high qualify CT scan are 0.14 mSv and 29.49 mSv, respectively. Radiation dose during transmission scan in the PET/CT system can measure using CTDI phantom with ionization chamber and anthropomorphic phantom with TLDs. further study need to be peformed to find optimal PET/CT acquisition protocols for reducing the patient exposure with same image qualify.

약지도 학습을 이용한 양파 질병 증상 자동 검출

한승훈 ( Seung-hoon Han ),강경민 ( Kyeong-min Kang ),김완수 ( Wan-soo Kim ),김용주 ( Yong-joo Kim ),이대현 ( Dae-hyun Lee ) 한국농업기계학회 2020 한국농업기계학회 학술발표논문집 Vol.25 No.1

농업 노동력 감소 및 1인당 재배면적의 증가는 작물의 일관되고 효율적인 질병 예찰을 어렵게 하고 있으며, 이를 해결하기 위해 자동 인식 기술 등의 무인화 시스템을 이용한 기술적인 대안이 필요한 실정이다. 본 연구에서는 양파 재배 자동화를 위해 수행되었으며, 딥러닝을 이용하여 양파 재배 영상 내 질병 증상을 자동으로 검출하였다. 양파 재배지의 실시간 감시가 가능한 영상 수집 시스템을 이용하여 학습용 영상데이터를 수집하였으며, 수집된 영상은 딥러닝 모델 학습을 위한 영상크기로 샘플링 한 후 영상단위로 라벨링을 수행하였다. 양파 질병 증상 검출을 위한 기반 모델은 VGG-16을 이용하였으며, 주석작업에 필요한 노동력 절감을 위해 영상단위 라벨링으로 객체 검출이 가능한 약지도 학습 방법을 이용하였다. 딥러닝 모델의 학습결과 학습 정확도는 약 93%, 검증 정확도는 약 82%, 시험 정확도는 약 70%로 각각 관찰되었으며, 활성화 맵을 이용하여 검출된 영역을 시각화한 결과 질병 증상의 검출이 가능한 것으로 판단되며, 임계값을 이용하여 검출된 질병 영역을 이진화한 후 전체 영상에 대한 비율을 발병도로 평가할 결과 0.6 ~ 7.0% 수준으로 나타났다. 또한, 본 연구 결과를 이용하여 임계값 변화에 따른 알람 단계를 결정하는 방법을 제시하였으며, 향후 기준에 대한 선정 방법의 세분화 및 검증을 통해 양파 질병에 대한 자동 알람 정보의 제공이 가능할 것으로 판단된다.

CT 영상을 이용한 감쇠 보정 시 조영제가 PET 영상에 미치는 영향

손혜경,권윤영,정해조,김희중,Son Hye-Kyung,Turkington Timothy G.,Kwon Yun-Young,Jung Haijo,Kim Hee-Joung 한국의학물리학회 2005 의학물리 Vol.16 No.4

본 연구에서는 PET/CT 시스템에서 CT 영상을 이용한 감쇠 보정 시 조영제가 PET 영상에 미치는 영향을 관찰하기 위해 팬텀실험과 모의실험을 수행하였다. 다양한 농도로 희석한 조영제를 채운 플라스틱 병을 스티로폼을 이용하여 전신 팬텀 내에 고정시킨 후 투과 영상을 획득하였다 모의실험을 위해 인체 기관 중간을 가진 수학적 방출 맵과 투과 맵을 각각 생성하였다. 조영제의 비균일 증강, 조영제의 다양한 농도 및 분포 크기, 잡음 정도, 영상의 해상도, 재구성 알고리듬, 조영제의 저-감쇠, 그리고 각각 다른 시간상에 대한 조영제의 분포의 차이와 같은 다양한 인자들에 대하여 평가하였다. 팬텀실험으로부터 CT의 Hounsfield 값이 조영제의 농도 및 전압 값에 의존함을 확인할 수 있었다. 모의실험으로부터 조영제가 감쇠 보정한 PET 영상에서 인공산물을 생성하고 영상의 질을 떨어뜨리는 것을 관찰할 수 있었다. 조영제의 영향은 조영제의 농도 및 분포 크기, 잡음 정도, 영상의 해상도 등에 의해 영향을 받는 것으로 나타났다. 본 연구 결과들은 임상적 PET/CT 영상에서 조영제로 인해 발생할 수 있는 잠재적 문제를 충분히 이해하고 이를 고려해야 함을 보여 주었다. Experiments and simulation were done to study the impact of contrast agent when CT scan was used to attenuation correction for PET Images in PET/CT system. Whole body phantom was imaged with various concentration of iodine-based contrast agent using CT. Mathematical emission and transmission density map with liver were made to simulate for whole body FDG Imaging. A variety of factors were estimated, including non-uniform enhancement of contrast agent, concentration and distribution size of contrast agent, noise level, image resolution, reconstruction algorithm, hypo-attenuation of contrast agent, and different time phases for contrast agent. Experimental studies showed that Hounsfield unit depends on the concentration of contrast agent and tube voltage. From the simulation data, contrast agents Introduced artifacts and degraded image quality on the attenuation-corrected PET images. The severity of these effects depends on a variety of factors, including the concentration and distribution size of contrast agent, the noise levels, and the Image resolution. These results Indicated that the impact of contrast agents should be considered with a full understanding of their potential problems in clinical PET/CT images.

Te - 124 Target로 생산된 I - 123 SPECT 영상에서의 조준기 선택

손혜경(Hye Kyung Son),이희경(Hee Kyung Lee),김희중(Hee Joung Kim),남기표(Ki Pyo Nam),봉정균(Joung Kyun Bong) 대한핵의학회 1996 핵의학 분자영상 Vol.30 No.3

N/A In the case of 123I from the 124Te(p,2n)reaction, the radionuclidic impurity is the high-energy gamma-emitting 124I, which interferes greatly with nuclear medicine images. The choice of a collimator can affect the quality of clinical SPECT images of [I-123]MIBG, [I-123]β-CIT, or [I-123]IPT. The tradeoffs that two different collimators make among spatial resolution, sensitivity, and scatter were studied by imaging a line source at 5cm, 10cm, 15cm distance using a number of plexiglass sheets between source and collimator, petridish, two-dimensional Hoffman brain phantom, Jaszczak phantom, and three-dimensional Hoffman brain phantom after filling with 123I. (FWHM, FWTM, Sensitivity) for low-energy ultrahigh-resolution parallel-hole(LEUHRP) collimator and medium-energy general-purpose(MEGP) collimator were measured as (9.27mm, 61.27mm, 129 CPM/ μCi) and (10.53mm, 23.17mm, 105CPM/μ/Ci), respectively. The image quality of two- dimensional Hoffman brain phantom with LEUHRP looked better than the one with MEGP. However, the image quality of Jaszczak phantom and three-dimensional Hoffman brain phantom with LEUHRP looked much worse than the one with MEGP because of scatter contributions in three-dimensional imaging situation. The results suggest that the MEGP is preferable to LEUHRP for three-dimensional imaging studies of [I-123]MIBG, [I-123] β-CIT, or [I-123] IPT.

[ I - 123 ] IPT 약역학 컴퓨터시뮬레이션을 이용한 민감도 측정 및 간편화된 운반체 정량분석 방법들의 비교분석 연구

손혜경(Hye Kyung Son),이희경(Hee Kyung Lee),김희중(Hee Joung Kim),나상균(Sang Kyun Nha) 대한핵의학회 1997 핵의학 분자영상 Vol.31 No.1

N/A Recently, [I-123]IPT SPECT has been used for early diagnosis of Parkinson's patients(PP) by imaging dopamine transporters. The dynamic time activity curves in basal ganglia(BG) and occipital cortex(OCC) without blood samples were obtained for 2 hours. These data were then used to measure dopamine transporters by operationally defined ratio methods of (BG-OCC)/OCC at 2 hrs, binding potential Rv=k3/k4 using graphic method or RA= (ABBG-ABOCC)/ABOCC for 2 hrs, where ABBG represents accumulated binding activity in basal ganglia(∫0 120minBG(t)dt) and ABOCC represents accumulated binding activity in occipital cortex(∫0 120minBG(t)dt). The purpose of this study was to examine the IPT pharmacokinetics and investigate the usefulness of simplified methods of (BG-OCC)/OCC, RA, and RA which are often assumed that these values reflect the true values of k3/k4. The rate constants K1, k2, k3 and k4 to be used for simulations were derived using [I-123]IPT SPECT and aterialized blood data with a standard three compartmental model. The sensitivities and time activity curves in BG and OCC were computed by changing K1 and k3(only BG) for every 5min over 2 hours. The values (BG-OCC)/OCC, RA, and Rv were then computed from the time activity curves and the linear regression analysis was used to measure the accuracies of these methods. The rate constants K1, k2, k3, k4 at BG and OCC were 1.26±5.41%, 0.044±19.58%, 0.031±24.36%, 0.008±22.78% and 1.36±4.76%, 0.170±6.89%, 0.007±23.89%, 0.007±45.09%, respectively. The Sensitivities for ((△S/S)/(△k3/k3)) and ((△S/△S)/(△K1/K1)) at 30min and 120min were measured as (0.19, 0.50) and (0.61, 0.23), respectively. The correlation coefficients and slopes of ((BG-OCC)/OCC, RA, and Rv) with k3/k4 were (0.98, 1.00, 0.99) and (1.76, 0.47, 1.25), respectively. These simulation results indicate that a late [1-123]IPT SPECT image may represent the distribution of the dopamine transporters. Good correlations were shown between (BG-OCC)/OCC, RA or Rv and true k3/k4,, although the slopes between them were not unity. Pharmacokinetic computer simulations may be very useful technique in studying dopamine transpoter systems.

전신 PET/CT 영상 획득 프로토콜을 이용한 유효선량 평가

남소라,손혜경,이상훈,이창래,조효민,김희중,Nam, So-Ra,Son, Hye-Kyung,Lee, Sang-Hoon,Lee, Chang-Lae,Cho, Hyo-Min,Kim, Hee-Joung 한국의학물리학회 2006 의학물리 Vol.17 No.3

본 연구는 임상 환경에서의 전신 PET/CT 영상 획득방식 조건에서 환자가 받는 피폭선량을 Alderson 팬텀과 TLD를 이용하여 측정하는 것이었다. Philips GEMINI PET/CT에서는 $^{137}Cs$ 투과 스캔과 이와의 비교를 위한 고화질 CT 투과 스캔 및 토포그램을 각각 수행하여 각 인체 장기별 선량을 측정하였다. GE DSTe PET/CT에서는 감쇄 보정용 CT투과 스캔과 진단용 전신 CT스캔 및 토포그램 그램을 각각 수행하여 인체 내 장기별 선량을 측정하였다. 여기서 각 인체 장기는 ICRP 60에서 추천하는 장기를 참고로 선택하였다. 또한 실험에 사용한 TLD는 10 MV X선을 사용하여 교정한 후 5% 이내의 정확도를 가지는 것만 사용하였다. 그 결과 Philips GEMINI PET/CT에서의 $^{137}Cs$ 선원을 이용한 투과 스캔의 유효선량은 $0.14{\pm}0.950mSv$, 고화질 CT투과 스캔에서의 유효선량은 $29.49{\pm}1.508mSv$, 토포그램에서의 유효선량은 $0.72{\pm}0.032mSv$로 나타났다. 또한 GE DSTe PET/CT에서 감쇄보정용 CT투과 스캔의 유효선량은 $20.06{\pm}1.003mSv$, 진단용 전신 CT스캔의 유효선량은 $24.83{\pm}0.805mSv$, 토포그램의 유효선량은 $0.27{\pm}0.008mSv$로 나타났다. 임상 환경에서의 PET/CT 영상을 획득했을 시 종합 피폭은 PET영상을 획득했을 때의 유효선량을 더함으로써 평가할 수 있었다. 그 결과 Philips GEMINI PET/CT (Topogram+$^{137}Cs$ transmission scan + PET, Topogram +high Quality CT+ PET)와 GE DSTe PET/CT (Topogram+CT attenuation map+PET, Topogram+CT for diagnosis+PET)에서 환자가 받는 총 유효선량들은 각각($7.65{\pm}0.951mSv$와 $37.00{\pm}1.508mSv$), ($27.12{\pm}1.003mSv,\;31.89{\pm}0.805mSv$)로 나타났다. PET/CT 영상 획득 시에 가능한 한 피폭은 적게 하면서도 진단이 가능한 화질을 유지할 수 있는 최적의 프로토콜 마련이 시급한 것으로 생각된다. The purpose of this study was to evaluate the radiation dose for clinical PET/CT protocols in clinical environments using Alderson phantom and TLDs. Radiation doses were evaluated for both Philips GEMINI 16 slice PET/CT system and GE DSTe 16 slice PET/CT system. Specific organ doses with $^{137}Cs$ transmission scan, high quality CT scan and topogram in philips GEMINI PET/CT system were measured. Specific organ doses with CT scan for attenuation map, CT scan for diagnosis and topogram in GE DSTe PET/CT system were also measured. The organs were selected based on ICRP60 recommendation. The TLDs used for measurements were selected for within an accuracy of ${\pm}5%$ and calibrated in 10 MV X-ray radiation field. The effective doses for $^{137}Cs$ transmission scan, high qualify scan, and topogram in Philips GEMINI PET/CT system were $0.14{\pm}0.950,\;29.49{\pm}1.508\;and\;0.72{\pm}0.032mSv$ respectively. The effective doses for CT scan to make attenuation map, CT scan to diagnose and topogram in GE DSTe PET/CT system were $20.06{\pm}1.003,\;24.83{\pm}0.805\;and\;0.27{\pm}0.008mSv$ respectively. We evaluated the total effective dose by adding effective dose for PET Image. The total PET/CT doses for Philips GEMINI PET/CT (Topogram+$^{137}Cs$ transmission scan+PET, Topogram+high qualify CT+PET) and GE DSTe PET/CT (Topogram +CT for attenuation map+ PET, Topogram+diagnostic CT+ PET) are $7.65{\pm}0.951,\;37.00{\pm}1.508,\;27.12{\pm}1.003\;and\;31.89{\pm}0.805mSv$ respectively. Further study may be needed to be peformed to find optimal PET/CT acquisition protocols for reducing the patient exposure with good image qualify.

전신 PET/CT 영상에서 조영제 영향의 보정 유.무에 따른 SUV 평가

남소라,손혜경,임한상,박훈희,조효민,이창래,김희중,Nam, So-Ra,Son, Hye-Kyung,Lim, Han-Sang,Park, Hoon-Hee,Cho, Hyo-Min,Lee, Chang-Lae,Kim, Hee-Joung 한국의학물리학회 2006 의학물리 Vol.17 No.4

본 연구의 목적은 전신 PET/CT영상에서 조영제의 영향에 대한 보정 유 무가 SUV (standard uptake value)에 미치는 영향을 평가하는 것이었다. 영상획득은 GE DSTe PET/CT 시스템을 사용하였으며, 간질환(hepatocellular carcinoma, HCC)과 신장질환(renal cell carcinoma, RCC)이 있는 환자를 대상으로 하여 영상을 평가하였다. 영상 평가는 조영제에 의한 영향을 보정한 영상과 보정하지 않은 영상에서 각각 동일한 위치에 같은 크기의 관심영역을 설정한 후 각 관심영역으로부터 구한 SUV를 비교함으로써 수행하였다. HCC 환자의 경우 조영제에 의한 영향의 보정 유 무에 따른 평균 SUV의 차이는 $1.5{\pm}1.2%$이었고, 최대 4.3%의 SUV 차이를 나타내었다. RCC 환자의 경우 평균 SUV의 차이는 $1.0{\pm}0.9%$이었고, 최대 1.9%의 SUV 차이를 나타내었다. 조영제를 사용한 PET/CT 영상에서 조영제에 의한 영향을 보정하지 않았을 경우는 조영제에 의한 영향을 보정해준 경우에 비해 상대적으로 높은 SUV를 나타내었다. 본 연구의 결과는 HCC 환자와 RCC 환자의 경우 조영제에 의한 영향을 보정한 경우와 보정하지 않은 경우 SUV에 큰 차이를 보이지는 않았으나, 향후 보다 많은 수의 HCC 환자와 RCC 환자를 대상으로 한 추가적인 연구가 필요할 것이라고 생각한다. 또한 다른 질환을 가진 환자의 경우에 대해서도 조영제가 SUV에 미치는 영향을 평가하는 것은 매우 유용하리라 생각한다. The purpose of this study was to evaluate SUV (standard uptake value) using different reconstruction methods in whole body PET/CT Imaging. PET/CT studies were peformed with and without correction for effect of contrast media. The patients data were acquired using GE DSTe commercial PET/CT system. The liver disease (hepatocellular carcinoma, HCC) and renal disease (renal ceil carcinoma, RCC) patients were selected for this study, The PET/CT data were reconstructed using post CT scan with and without correction for effect of contrast media. We selected ROIs (region of Interest) at the same location and same area for the same patient to compare SUVs in these two methods. For HCC and RCC, the average differences of SUVs were measured as $1.5{\pm}1.2%\;and\;1.0{\pm}0.9%$, respectively. For HCC and RCC, the maximum differences of SUVs were measured as 4.3% and 1.9%, respectively. We observed that SUVs without correction for effect of contrast media were higher than SUVs with correction for effect of contrast media. However the differences of SUVs were very minimal. These results may be limited to HCC and RCC and further studies will be Heeded for other organs or diseases to see any changes in SUV with and without correction for effect of contrast media.

게이트 Tc-99m 심근관류 SPECT에서 산란보정이 심근관류 및 좌심실기능평가에 미치는 영향

정환정(Hwan Jeong Jeong),손혜경(Hye Kyung Son),범희승(Hee Seung Bom) 대한핵의학회 2001 핵의학 분자영상 Vol.35 No.1

N/A Purpose: The purpose of this study was to evaluate the effect of scatter correction on the assessment of myocardial perfusion and left ventricular function by gated Tc-99m myocardial SPECT. Materials and Methods: Subjects were 11 normal volunteers, 20 patients with non-cardiac chest pain and 13 patients with coronary artery diseases. We classified above 3 groups into normal and diseased groups. Scatter correction was done using dual-energy-window scatter correction method (DEW-SC). We compared acquired counts, image contrast, corrected maximum relative counts, indices of left ventricular function, extent and severity of perfusion defects calculated by 'CEqual program’between scatter non-corrected and corrected images. Results: Scatter corrected studies was lower in counts by 18±3% than uncorrected studies, but image contrast were improved in all cases. Scatter correction using DEW-SC took 3 minutes to complete, and 512 kB memory to store. There were no significant differences among indices of left ventricular function between scatter non-corrected and corrected images. Although extents of perfusion defects were not significantly different, severity was severer in scatter corrected images. Conclusion: Scatter correction using DEW-SC is simple to do, and improves image contrast without changing other indices of myocardial perfusion and function. (Korean J Nucl Med 2001;35:33-42)

GE AdvanceTM 양전자방출단층촬영기의 표준 성능평가

정하규(Ha Kyu Jeong),김희중(Hee Joung Kim),손혜경(Hye Kyung Son),봉정균(Jung Kyun Bong),정해조(Hai Jo Jung),전태주(Tae Joo Jeon),김재삼(Jae Sam Kim),이종두(Jong Doo Lee),유형식(Hyung Sik Yoo) 대한핵의학회 2001 핵의학 분자영상 Vol.35 No.2

N/A Purpose: The purpose of this study was to establish optimal imaging acquisition conditions for the GE AdvanceTM PET imaging system by performing the acceptance tests designed by National Electrical Manufacturers Association (NEMA) protocol and General Electric Medical Systems (GEMS) test procedures. Materials and Methods: Performance tests were carried out with 18FDG radioactivity source and phantoms by using a standard acquisition mode. Transaxial resolution and scatter fraction tests were performed with a line source and axial resolution with a point source, respectively. A cylindrical phantom made of polymethylmethacrylate (PMMA) was used to measure sensitivity, count rate losses and randoms, uniformity correction, and attenuation inserts were added to measure remaining tests. The test results were acquired in a diagnostic acquisition mode and analyzed mainly on high sensitivity mode. Results: Transaxial resolution and axial resolution were measured as average of 4.65 mm and 3.98 mm at 0 cm, and 6.02 mm and 6.71 mm at 20 cm on high sensitivity mode, respectively. Average scatter fraction was 9.87%, and sensitivity was 225.8 kcps/ Ci/cc of trues. Activity at 50% deadtime was 4.6 Ci/cc, and the error of count rate correction at that activity was from 1.49% to 3.83%. Average nonuniformity for total slice was 8.37%. The accuracy of scatter correction was -0.95%. The accuracies of attenuation correction were 5.68% for air, 0.04% for water and -6.51% for polytetrafluoroethylene (PTFE). Conclusion: The results satisfied most acceptance criteria, indicating that the GE AdvanceTM PET system can be optimally used for clinical applications. (Korean J Nucl Med 2001;35:100-112)

Risperidone의 급성 및 만성 투여가 흰쥐 뇌의 Serotonin과 Dopamine수용체에 미치는 영향

최윤영(Yun Young Choi),문대혁(Dae Hyuk Miin),손혜경(Hye Kyung Son),김창윤(Chang Yoon Kim),이철(Chul Lee),이희경(Hee Kyung Lee) 대한핵의학회 1997 핵의학 분자영상 Vol.31 No.1

N/A The therapeutic efficacy of antipsychotic drugs is generally attributed to their ability to block dopamine D2 receptors. Classical D2 antagonists are not effective to treat negative symptoms and produce extrapyramidal side effects. On the other hand, atypical antipsychotic agents ameliorate negative symptoms without producing extra-pyramidal side effects, and it is reported to be associated with blockade of serotonin 5-HT2 receptors. The purpose of this study was to evaluate the effect of risperidone on neuroreceptors in the rat brain by quantitative autoradiography method. In acute treatment group, risperidone was injected into peritoneal cavity of male Wistar rats with dose of 0, 0.1, 0.25, 0.5, 1,0 and 2.0mg/kg in each Group(5/group), and they were decapitated after 2 hours. In chronic treatment group, risperidone was injected with dose of 0, 0.1, and 1mg/kg(I.P.) for 21 days and decapitated after 24 hours following last treatment. The effect of risperodone on the binding of [3H]spiperone to 5-HT2 and D2 receptors were analysed in 4 discrete regions of the striatum, nucleus accumbens, and frontal cortex by quantitative autoradiography. Acute treatment with risperidone reduced cortical 5-HT2 specific [3H]spiperone binding to 32% of vehicle-treated control. Subcortical 5-HT2 specific [3H]spiperone binding was not affected at all dose groups whereas a significant reduction (57%) in D2 specific [3H]spiperone binding was observed in risperidone treated group at doses of l-2mg/kg. Chronic treatment with risperidone produced a decrease in the maximal number of cortical 5-HT2 receptors to 51% and 46% of control in 0.1mg/kg & 1mg/kg treated group respectively. In conclusion, risperidone is a cortical serotonin receptor antagonist with relatively weak antagonistic action on dopamine receptors. These effects on neuroreceptors may explain the therapeutic effect of risperidone as a atypical antipsychotic agents.